Breast Cancer Bundle of Care project wins innovation award

Breast Cancer Bundle of Care, Genesis Care, in partnership with University Technology Sydney, University of Western Australian, and the University of Melbourne wins Value-Based Health Care (VBHC) Awards at the Value-Based Health Care Congress in Brisbane.

The aim of this early-stage breast cancer bundle pilot is to deliver a ‘joined up’, holistic 12-month package of care that supports best practice care for people newly diagnosed with breast cancer undertaking treatment in the private health system, providing upfront transparency in fees with measurable outcomes. The key objectives of the bundle are to improve patient experience, create financial transparency and certainty, improve patient outcomes and to create a sustainable scalable model. View the Breast Cancer Bundle of Care Virtual Poster.

All.Can International launched its latest policy report Harnessing data for better cancer care

The report assesses the essential role of data in cancer care to improve outcomes for all people with cancer. It offers policymakers, care providers, patients and decision-makers a forward-looking view of how to ensure high-quality health data are systematically collected and used to improve outcomes for patients across the entire cancer care pathway.

Download the full report here.

Download a report summary here.

Three Australian health services honoured in the Value-Based Health Care Awards

Dental Health Services Victoria (DHSV), Sydney Local Health District and Concord Repatriation General Hospital are the three winners honoured in today’s Value-Based Health Care Awards.

The awards were presented at the inaugural Value-Based Health Care Conference in Perth, co-hosted by the Australian Healthcare and Hospitals Association’s Australian Centre for Value-Based Healthcare and the Continuous Improvement in Care Cancer Project.

‘Australian health services are leading the way in value-based health care through innovative, inspiring and collaborative projects that are improving patient outcomes and reducing costs,’ said Australian Healthcare and Hospitals Association (AHHA) Chief Executive Adj Prof Alison Verhoeven. Read more here

Science on the Swan Conference 2020

The Science on the Swan Conference this year (17-19 May 2020) will incorporate a stream relating to health system performance and value-based health care, including levers to drive cost and positive outcomes.  Keynote speakers for this area of interest include Jason M. Sutherland, Professor in the Centre for Health Services and Policy Research (CHSPR) in the University of British Columbia and  Hugo Mascie-Taylor, Executive Medical Director at Ernst and Young UK.

Dr. Sutherland studies funding policy, methods for improving cross-continuum care, and health systems’ variations in efficiency, effectiveness and quality of care.  Dr Mascie-Taylor has worked on projects involving clinical governance, performance improvement, and service configuration.

For further information see https://scienceontheswan.com.au/

All.Can international launch a report titled ‘Patient insights on cancer care"

All.Can international has launched a report titled ‘Patient insights on cancer care: opportunities for improving efficiency’. It reveals findings from an international survey on the patient perspectives of inefficiencies in cancer care. With insights from almost 4,000 patients in over 10 countries, the report identifies four key areas of opportunity for improvement and highlights the need to establish a sustainable approach to cancer care.

Currently, at least 20% of total healthcare spending is estimated to be wasted on inefficient care, representing a crucial opportunity to improve the quality of care.

Download the report and find out more. http://bit.ly/AC-patient-survey

01-launch-FB LI.png

New program to place WA at forefront of cancer care

A ground-breaking program that will fundamentally change approaches to cancer care in Western Australia, being led by St John of God Subiaco Hospital’s Director of Breast Cancer Research Unit, has received a $750,000 grant from the Cancer Research Trust (CRT).